Avadel Pharmaceuticals plc (AVDL) financial statements (2021 and earlier)

Company profile

Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
DUBLIN, 15
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments73641394154145
Cash and cash equivalents72109173965
Short-term investments15437811580
Receivables191014171912
Inventory, net of allowances, customer advances and progress billings 45634
Inventory 45634
Prepaid expense122733
Other current assets000   
Other undisclosed current assets170391013
Total current assets:26382125124181166
Noncurrent Assets
Operating lease, right-of-use asset3 
Property, plant and equipment012333
Intangible assets, net (including goodwill)1719201114134
Goodwill171818181818
Intangible assets, net (excluding goodwill) 12922316
Other noncurrent assets2539361080
Deferred tax assets, net  1012
Other undisclosed noncurrent assets310752 
Total noncurrent assets:4869651296449
TOTAL ASSETS:312151190253245215
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities92625592614
Accounts payable3647711
Accrued liabilities7202251174
Taxes payable  0010
Debt  0000
Due to related parties 692534 
Business combination, contingent consideration, liability     29
Deferred revenue and credits225
Contract with customer, liability0
Other liabilities543100
Other undisclosed current liabilities01    
Total current liabilities:153638876249
Noncurrent Liabilities
Long-term debt and lease obligation130122116011
Long-term debt, excluding current maturities128122116011
Operating lease, liability2 
Liabilities, other than long-term debt421338114098
Deferred tax liabilities, net   1
Due to related parties 121974135 
Other liabilities4914752
Business combination, contingent consideration, liability     94
Other undisclosed noncurrent liabilities 2    
Total noncurrent liabilities:1341451498114198
Total liabilities:149181188168203147
Stockholders' equity
Stockholders' equity attributable to parent162(29)3864268
Preferred stock0     
Common stock100006
Treasury stock, value (50)(50)(22)  
Additional paid in capital567434434393385364
Accumulated other comprehensive loss(21)(23)(23)(23)(24)(23)
Accumulated deficit(384)(391)(358)(263)(320)(280)
Total stockholders' equity:162(29)3864268
TOTAL LIABILITIES AND EQUITY:312151190253245215

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2259103173150173
Revenue, net173150173
Cost of revenue(6)(17)(25)(23)(27)(23)
Cost of goods and services sold(6)(12)(18)(16)(13)(11)
Gross profit:164278151123150
Operating expenses(10)(66)(183)(61)(128)(78)
Operating income (loss):6(24)(105)90(5)71
Nonoperating income (expense)(1)(2)24313
Investment income, nonoperating(1)(2)0323
Foreign currency transaction gain (loss), before tax   (1)111
Other nonoperating income (expense)(0)(0)22  
Interest and debt expense(13)(12)(11)(1)(8)(6)
Other undisclosed income from continuing operations before equity method investments, income taxes3     
Income (loss) from continuing operations before income taxes:(5)(39)(113)93(10)78
Income tax expense (benefit)12518(24)(32)(38)
Net income (loss) available to common stockholders, diluted:7(33)(95)68(41)41

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):7(33)(95)68(41)41
Comprehensive income (loss):7(33)(95)68(41)41
Other undisclosed comprehensive income (loss), net of tax, attributable to parent21(0)0(1)(15)
Comprehensive income (loss), net of tax, attributable to parent:9(33)(95)69(42)25

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: